(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride

[email protected]
(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride
Trade Name
Orphan Indication Acute lymphoblastic leukemia
USA Market Approval USA
USA Designation Date 2004-08-13 00:00:00
Sponsor Mundipharma Research Limited;Cambridge Science Park, Cambridge CB4 0GW;England
Related Access Program
Novartis Pharmaceuticals – Acute Lymphoblastic Leukemia University of California, San Francisco – Acute Lymphoblastic Leukemia ERYtech Pharma – Acute Lymphoblastic Leukemia University of California, San Francisco – Acute lymphoblastic leukemia ERYtech Pharma – Acute lymphoblastic leukemia Amgen – Acute lymphoblastic leukemia